At STR Biotechnologies, all products are developed and manufactured based on scientific evidence, clinical research, and the latest advancements in regenerative medicine. Our PRP, PRF, CGF, SVF, and cellular therapy systems are designed with a strong focus on cell viability, biological effectiveness, and clinical performance. Through rigorous validation and performance studies conducted in accordance with international quality standards, we continuously assess and enhance the reliability of our products. Guided by a science-driven approach, STR Biotechnologies is committed to delivering innovative, evidence-based solutions that support healthcare professionals worldwide.